Search Results - "Lafferty, M H"

Refine Results
  1. 1

    Association of Blood Monocyte and Lymphocyte Count and Disease-Free Interval in Dogs with Osteosarcoma by Sottnik, J.L, Rao, S, Lafferty, M.H, Thamm, D.H, Morley, P.S, Withrow, S.J, Dow, S.W

    Published in Journal of veterinary internal medicine (01-11-2010)
    “…Background: Identification of biomarkers that predict outcomes in dogs with osteosarcoma (OSA) would be valuable to veterinarians and owners. Leukocyte numbers…”
    Get full text
    Journal Article
  2. 2

    Enkephalinase Inhibition Increases Plasma Atrial Natriuretic Peptide Levels, Glomerular Filtration Rate, and Urinary Sodium Excretion in Rats With Reduced Renal Mass by Lafferty, Helen M, Gunning, Mark, Silva, Patricio, Zimmerman, Mark B, Brenner, Barry M, Anderson, Sharon

    Published in Circulation research (01-09-1989)
    “…To investigate the in vivo effects of inhibition of endopeptidase 24.11, an enkephalinase enzyme shown to be involved in atrial natriuretic peptide (ANP)…”
    Get full text
    Journal Article
  3. 3

    Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991) by Ogilvie, G K, Straw, R C, Jameson, V J, Walters, L M, Lafferty, M H, Powers, B E, Withrow, S J

    “…A study was undertaken to determine the effect chemotherapy had when used to treat 45 dogs with measurable metastatic osteosarcoma. The primary tumor was…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Renal hemodynamic and natriuretic effects of manganese and interactions with atrial natriuretic peptide by Lafferty, H M, Gunning, M, Brady, H R, Brenner, B M, Anderson, S

    Published in The American journal of physiology (01-04-1990)
    “…Manganese (Mn2+) is a cofactor for guanylate cyclase (GC), which is involved in the generation of guanosine 3',5'-cyclic monophosphate (cGMP), a second…”
    Get full text
    Journal Article
  6. 6

    Evaluation of a one-hour saline diuresis protocol for administration of cisplatin to dogs by Ogilvie, G K, Fettman, M J, Jameson, V J, Walters, L M, Lafferty, M H, Cooper, M F, Powers, B E, Ciekot, P A, Atwater, S W, Withrow, S J

    Published in American journal of veterinary research (01-09-1992)
    “…A study was undertaken to determine the toxic effects of cisplatin, an antineoplastic agent, when administered immediately after a 1-hour saline diuresis. Four…”
    Get more information
    Journal Article
  7. 7

    Curative-intent radiation therapy as a treatment modality for appendicular and axial osteosarcoma: a preliminary retrospective evaluation of 14 dogs with the disease by Walter, C. U., Dernell, W. S., LaRue, S. M., Lana, S. E., Lafferty, M. H., LaDue, T. A., Withrow, S. J.

    Published in Veterinary & comparative oncology (01-03-2005)
    “…Canine osteosarcoma is a common bone malignancy associated with aggressive local disease and rapid metastasis. Current local therapeutic modalities do not…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Adjuvant chemotherapy using cisplatin by subcutaneous administration by Dernell, W S, Withrow, S J, Straw, R C, Lafferty, M H

    Published in In vivo (Athens) (01-07-1997)
    “…BACKGROUND-MATERIALS: Based on previous polymer release experience, this study was conducted to evaluate the toxicity, efficacy and systemic absorption of…”
    Get more information
    Journal Article
  11. 11

    Anemia ameliorates progressive renal injury in experimental DOCA-salt hypertension by Lafferty, H M, Garcia, D L, Rennke, H G, Troy, J L, Anderson, S, Brenner, B M

    “…To explore the role of systemic hematocrit in the vascular adaptations which characterize desoxycorticosterone-salt hypertension, studies were performed in…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20